• Showcasing ESG Achievements and Future Corporate Vision
• Reaffirming Commitment to Becoming a "Sustainable Global Healthcare Company

Ildong Pharmaceutical, led by CEO Yun Woongsup, has published its 2024 Sustainability Management Report, outlining the company’s current ESG (Environmental, Social, and Governance) initiatives and its future direction.

The company explained that the report was designed to transparently disclose key ESG activities, achievements, and medium- to long-term strategies to stakeholders while actively fostering communication.

The report, which covers activities from January to December 2023, consists of:

• Company Overview
• ESG Management Framework and Achievements
• ESG Status by Sector (Environmental, Social, and Governance)
• Related Data and Appendices

The content adheres to the GRI Standards, an international sustainability reporting guideline.

Through stakeholder feedback, the company identified five key sustainability issues:

1. Development of competitive new products
2. Climate change response and establishment of a carbon-neutral framework
3. Strengthening anti-corruption compliance
4. Talent acquisition and enhancement of human resource capabilities
5. Improvement of product quality and safety management

The report highlights Ildong Pharmaceutical's efforts, initiatives, and achievements in these areas.

Recognizing the global urgency of climate change, Ildong has proposed actionable measures in response. The company has committed to reducing greenhouse gas emissions by 20% by 2030 and achieving carbon neutrality by 2050. This strategy includes analyzing the impact of climate-related risks on business operations through a "Climate Change Response Scenario Analysis."

Under its corporate philosophy of contributing to "the health and happiness of humanity," Ildong has prioritized ESG management. Since establishing its ESG Committee in 2017, the company has expanded its ESG efforts by creating a dedicated ESG department and consultative body. These organizations integrate ESG principles into management indicators, policies, and operational strategies.

The company actively participates in various social contribution activities, including donations and sponsorships. Recently, Ildong launched the "Ildong-i Volunteer Group" to promote environmental protection campaigns and activities supporting socially vulnerable groups. This initiative emphasizes employee-driven participation.

Ildong Pharmaceutical has reaffirmed its commitment to becoming a "Sustainable Global Healthcare Company." The company aims to adapt effectively to external market challenges, maximize corporate value, and meet stakeholder expectations by advancing its ESG management practices.